About: Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 November 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в березні 2013 (uk) im März 2013 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2012 (ast) scientific article published on 09 November 2012 (en) գիտական հոդված հրատարակված 2012 թվականի նոյեմբերի 9-ին (hy)
publication date	wds:Q57972640-DC717C2B-67C7-4B30-8562-4362D20D79AE
publication date	2012-11-09 00:00:00Z (xsd:dateTime)
author name string	wds:Q57972640-167664DD-DB3A-4FD5-8691-02553C68BD68 wds:Q57972640-2B4B0FA3-2EEF-4B93-9333-6787AFC02D0D wds:Q57972640-2FC6F819-A956-4BAD-B0E7-A7B30123A4C6 wds:Q57972640-413867C6-1C90-4C0A-BAFE-5358EAF481F2 wds:Q57972640-6DBFB5E9-9D18-4718-A90E-3529D7A28552 wds:Q57972640-73D5DA6D-7DBE-4D01-A402-670775DCD34B wds:Q57972640-8621A22C-D810-4670-9CC5-BBEE82E6F193 wds:Q57972640-8D6AF533-7EEA-47BD-834F-933B134CE055 wds:Q57972640-D8C383C6-D19E-4B6E-8B33-4BA32E6FBBF4 wds:Q57972640-DD55CAE6-A5E5-4C6F-A3C6-25C92D1EE96A wds:Q57972640-E99C8EE9-F016-4890-8039-5C16A25E0357
author name string	Fabio De Vincenzo Paolo A Zucali Luca Rubino Giovanna Masci Monica Zuradelli Elena Lorenzi Matteo Perrino Luca Mancini Monica Bertossi Matteo B Suter Giuseppe Fattuzzo
rdfs:label	Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (en) Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (nl)
skos:prefLabel	Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (en) Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (nl)
name	Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (en) Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (nl)
author	wds:Q57972640-263B60C0-A980-4BEE-8F18-255D26F3D7C7 wds:Q57972640-26762EAF-84D7-41F5-A118-5F54AC7A45B4 wds:Q57972640-7165E7D5-FD93-4E9A-93D0-2FE1263219A7 wds:Q57972640-B2F5B50D-619B-4C0C-A0AB-1770F62E88A0 wds:Q57972640-BA1FD6D4-EEEF-4F07-AC38-5239C093803E wds:Q57972640-D00D0EB8-CD4B-46B5-996F-AE33C8B22395 wds:Q57972640-EB168E41-7672-4071-96F0-5E9143578D73
author	Armando Santoro Rita De Sanctis Luca Di Tommaso Lorenza Rimassa Matteo Simonelli Massimo Roncalli Laura Giordano
title	wds:Q57972640-9BC5524B-D559-4B18-ADAF-49FD41E5F19D
title	Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors (en)
page(s)	wds:Q57972640-00ED8E45-3E4C-481D-91A9-E42DCD4C35EE
page(s)	989-998
instance of	wds:Q57972640-04462792-F83C-4497-9BA6-D0066288E42D
instance of	scholarly article
main subject	wds:Q57972640-7E66B107-F8DB-43FE-83C8-17C0B486747F
main subject	cancer research
PubMed ID	wds:Q57972640-8BDABA95-95A9-4A9A-9226-1A3DAFC46F4A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23146956
PubMed ID	23146956
published in	wds:Q57972640-86C4B205-167D-4900-AAD3-3B26E7D3310B
published in	European Journal of Cancer
issue	wds:Q57972640-31A5D46D-B7DB-428F-A5E3-E17669AC947D
volume	wds:Q57972640-5EEA936B-C0CC-4BB5-9D22-13C32C287705
issue	5
volume	49
DOI	wds:Q57972640-C3BA254B-52A7-4CC0-88A8-214ACC256B4C
DOI	http://dx.doi.org/10.1016/J.EJCA.2012.10.016
DOI	10.1016/J.EJCA.2012.10.016
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57972640
is cites work of	Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports. Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies. Multi-kinase modulation for colon cancer therapy
is cites work of	wds:Q38400475-E9C87E70-7E25-4F8B-8B80-E6E9176CCF31 wds:Q36270115-BF9C98A5-70C2-4B57-B791-DB754C7D32E7 wds:Q35115436-D66BF108-C07C-4F66-BFD0-D73C83006DCC wds:Q37589220-4C85A615-74AC-4AA1-8792-FFA2D6476AA6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software